CGP-43371
CGP-43371, a Rifampicin (HY-B0272) derivative, is an orally active hypolipidemic agent. CGP-43371 has hypolipidemic and anti-atherosclerotic activities[1].
Product Specifications
CAS Number
[123036-23-7]
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cardiovascular Disease
Smiles
O=C(C(C)(C)C)OC(C(C(OC(/C(C)=C\C=C\[C@@H]([C@@H]([C@H]1C)O)C)=N2)=C2C(N3CCN(CC(C(C)=CC(C)=C4)=C4C)CC3)=C5O)=C5C6=C7O[C@](C)(O/C=C/[C@@H]([C@H]([C@@]([C@H](C)[C@@H]1O)([H])OC(C)=O)C)OC)C6=O)=C7C
Molecular Formula
C56H73N3O12
Molecular Weight
980.19
References & Citations
[1]Feldman DL, et al. CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formation. Atherosclerosis. 2001 Feb 1;154 (2) :317-28.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-19159/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
